Black and Native American patients were 23% less likely to have an elevated CA-125 level at ovarian cancer diagnosis compared with white patients, suggesting the current thresholds are set too high.

There is a Change.org petition circulating saying just that, based on the claim that the association’s clinical exam is biased because from 2018 to 2021 84 percent of white test-takers passed it ...

The test isn’t perfect for white ... analyzed data from more than 200,000 women with ovarian cancer from 2004 through 2020 who’d had a CA-125 blood test. Black and Native American patients ...

The test isn’t perfect for white ... analyzed data from more than 200,000 women with ovarian cancer from 2004 through 2020 who’d had a CA-125 blood test. Black and Native American patients ...

Black and Native American patients were 23% less likely to have an elevated CA-125 level at ovarian cancer diagnosis compared with white patients, suggesting the current thresholds are set too high.

Black and Native American patients were 23% less likely to have an elevated level on the blood test compared with white patients, suggesting the thresholds are too high.